HER-2 Positive Breast Cancer Completed Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0042425 (HER-2 Positive Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00788931A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast CancerTreatment